[HTML][HTML] Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches

DJ Medina-Leyte, O Zepeda-García… - International journal of …, 2021 - mdpi.com
Coronary artery disease (CAD) and its complications are the leading cause of death
worldwide. Inflammatory activation and dysfunction of the endothelium are key events in the …

[HTML][HTML] Inhibition and induction of CYP enzymes in humans: an update

J Hakkola, J Hukkanen, M Turpeinen, O Pelkonen - Archives of Toxicology, 2020 - Springer
The cytochrome P450 (CYP) enzyme family is the most important enzyme system catalyzing
the phase 1 metabolism of pharmaceuticals and other xenobiotics such as herbal remedies …

[HTML][HTML] Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017

C Hiemke, N Bergemann, HW Clement… - …, 2018 - thieme-connect.com
Therapeutic drug monitoring (TDM) is the quantification and interpretation of drug
concentrations in blood to optimize pharmacotherapy. It considers the interindividual …

Drug repurposing for antimicrobial discovery

MA Farha, ED Brown - Nature microbiology, 2019 - nature.com
Antimicrobial resistance continues to be a public threat on a global scale. The ongoing need
to develop new antimicrobial drugs that are effective against multi-drug-resistant pathogens …

[HTML][HTML] Systematic analysis of drug combinations against Gram-positive bacteria

E Cacace, V Kim, V Varik, M Knopp, M Tietgen… - Nature …, 2023 - nature.com
Drug combinations can expand options for antibacterial therapies but have not been
systematically tested in Gram-positive species. We profiled~ 8,000 combinations of 65 …

[HTML][HTML] Revisited: therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics

M Schulz, A Schmoldt, H Andresen-Streichert… - Critical Care, 2020 - Springer
In order to assess the significance of drug/substance levels measured in intensive care
medicine and clinical and forensic toxicology as well as for therapeutic drug monitoring, it is …

Abuse and misuse of pregabalin and gabapentin

KE Evoy, MD Morrison, SR Saklad - Drugs, 2017 - Springer
Background Gabapentinoid (pregabalin and gabapentin) abuse is increasingly being
reported. Objective To assess the extent of gabapentinoid abuse, characteristics of typical …

Prospective countywide surveillance and autopsy characterization of sudden cardiac death: POST SCD study

ZH Tseng, JE Olgin, E Vittinghoff, PC Ursell, AS Kim… - Circulation, 2018 - Am Heart Assoc
Background: Studies of out-of-hospital cardiac arrest and sudden cardiac death (SCD) use
emergency medical services records, death certificates, or definitions that infer cause of …

[HTML][HTML] A review of the pharmaceutical exposome in aquatic fauna

TH Miller, NR Bury, SF Owen, JI MacRae… - Environmental …, 2018 - Elsevier
Pharmaceuticals have been considered 'contaminants of emerging concern'for more than 20
years. In that time, many laboratory studies have sought to identify hazard and assess risk in …

How addictive are gabapentin and pregabalin? A systematic review

U Bonnet, N Scherbaum - European neuropsychopharmacology, 2017 - Elsevier
In the last ten years, gabapentin and pregabalin have been becoming dispensed broadly
and sold on black markets, thereby, exposing millions to potential side-effects. Meanwhile …